Measuring the efficiency of large pharmaceutical companies: an industry analysis

dc.contributor.author	Gascón García-Ochoa, Fernando
dc.contributor.author	Lozano Mosterín, Jesús
dc.contributor.author	Ponte Blanco, Borja
dc.contributor.author	Fuente García, David Alfonso de la
dc.date.accessioned	2017-02-01T07:39:49Z
dc.date.available	2017-02-01T07:39:49Z
dc.date.issued	2017
dc.identifier.citation	European Journal of Health Economics, 18, p. 587–608 (2017); doi:10.1007/s10198-016-0812-3
dc.identifier.issn	1618-7598
dc.identifier.uri	http://hdl.handle.net/10651/39563
dc.description.sponsorship	Fernando Gascón would like to acknowledge financing from the Government of Spain through national research project ECO2012-31772. Borja Ponte would like to thank the Government of the Principality of Asturias for financially supporting his work through the Severo Ochoa program (reference BP13011). We also would like to thank professor Laura Cabiedes for her helpful comments and suggestions.
dc.format.extent	p. 587–608
dc.language.iso	eng
dc.relation.ispartof	European Journal of Health Economics
dc.rights	©,
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976274335&partnerID=40&md5=fe23c9825b7245704bc81a48a3d00f15
dc.title	Measuring the efficiency of large pharmaceutical companies: an industry analysis
dc.type	journal article
dc.identifier.doi	10.1007/s10198-016-0812-3
dc.relation.projectID	ECO2012-31772
dc.relation.projectID	BP13011
dc.relation.publisherversion	http://dx.doi.org/10.1007/s10198-016-0812-3

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.